With a drill imminent that can add 100-200% or dump the share please show me any kind of maths that says it's a buy at 2.8c but not at 3.1c.
On conventionals only Cyrene could return 201.48% at 2.9c and 188.48% at 3.1c based on discovery value alone (at $18bbl). Given that is the current focus of the company (and therefore primary valuation factor for the next few months) how does risk adjusted leverage (at 12% gPOS) of 24% cry out for investment vs 22.6%? Or do you not do your homework before investing?
If you have any kind of actual mathematical rationale that differentiates the two, except for your gut, the vibe or Mabo I'm all ears and happy to be educated. However it sounds like even though the stock can be punished to 2.0c at the whim of the JV partner or failure at Cyrene you're completely happy buying up 1-2% of the company if it was just 10% cheaper. Doesn't seem like you've really thought it through at all.
Coming here complaining about moving offices, how fragile the company is and how we should make sure the sleeping pills and razor blades are kept in a locked up cupboard to take it down to 2.8c and then make a few pips and a couple of grand is exactly what I'm insinuating you're doing (even though according to your logic you'd be in imminent danger of losing it as well) given you haven't given any kind of rationale.
kisses ;)
- Forums
- ASX - By Stock
- KEY
- principal place of business
principal place of business , page-12
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KEY (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.262M |
Open | High | Low | Value | Volume |
0.1¢ | 0.1¢ | 0.1¢ | $11 | 11K |
Featured News
KEY (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online